Commercialization
AS GOVERNMENTS SQUEEZE COSTS AND COMPETITION MOUNTS IN MATURING MARKETS, GROWTH IS MOVING ELSEWHERE.
But even though the emerging markets offer unlimited scope for expansion, they’re dominated by generics, and might not have the budgets or government will to fund your branded products.
Our expertise and in-depth market knowledge can help you manage your patent portfolio more effectively, ensuring all your application and renewal dates are known and met and maximizing your protection against potential generic competition.
Intelligence, tools and expertise to support your scientific messaging, marketing, product positioning, and awareness campaigns.
Key Solution
Thomson Reuters Pharma: Competitor intelligence database integrating more than 40 pharmaceutical data sources, unique abstracts, commentaries and analysis.
Comprehensive intelligence and analysis to identify in/out licensing of potential therapeutics, partnering opportunities and new commercial prospects.
Key Solution
Thomson Reuters Forecast: The most accurate available method of assessing the sales potential of new drugs by integrating and summarizing multiple perspectives on drugs that will compete with yours.
Pipeline and competitor knowledge to help you optimize your product portfolio, monitor industry developments and make better decisions.
Key Solution
Thomson Reuters Pharma: Competitor intelligence database integrating more than 40 pharmaceutical data sources, unique abstracts, commentaries and analysis.
Feedback